| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |